Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
Urologic Oncology: Seminars and Original Investigations | Oct 08, 2017
Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis
Urologic Oncology: Seminars and Original Investigations | Oct 05, 2017
Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Oct 04, 2017
Decreasing suicide risk among patients with prostate cancer: Implications for depression, erectile dysfunction, and suicidal ideation screening
Urologic Oncology: Seminars and Original Investigations | Oct 03, 2017